76 results
8-K
EX-99.1
VANI
Vivani Medical, Inc.
13 Aug 24
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
4:29pm
as of March 31, 2024. The decrease of $4.7 million is attributed to a net loss of $5.4 million, partially offset by $0.6 million in non-cash items
8-K
EX-99.1
VANI
Vivani Medical, Inc.
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
of property and equipment, stock-based compensation and lease expense, partially offset by a net loss of $6.0 million and $0.2 million used for purchase … to a decrease in costs from the Company’s wholly owned subsidiary Cortigent and drug implant development costs, partially offset by increased payroll
DEFA14A
VANI
Vivani Medical, Inc.
29 Apr 24
Additional proxy soliciting materials
4:32pm
materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
8-K
EX-99.1
md5aykv
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
424B5
8bl63o
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
b8fqxnglau8mk
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.2
q2go7vzqel 95upwj
15 May 23
Results of Operations and Financial Condition
6:49am
DEFR14A
tprxqdiqw91th1g
1 May 23
Revised proxy
4:49pm
DEFA14A
et7rc8 nqeh
28 Apr 23
Additional proxy soliciting materials
11:29am
8-K
EX-10.1
95sd qunlmcwmmr90m9
28 Nov 22
Entry into a Material Definitive Agreement
5:29pm